Clinical Trial

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

Study acronym: DmannoseRCT
Recruiting
View on ClinicalTrials.gov →
Summary
A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-15.
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT06940622
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Recurrent UTIs, Recurrent Urinary Tract Infections, Recurrent Urinary Tract Infections in Women, Recurrent Urinary Tract Infection, Cystitis Recurrent, Cystitis Chronic, UTI, UTI - Urinary Tract Infection +1 more
Enrollment 90 participants
Start Date 2025-08-01
Primary Completion 2029-09-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-22